Related Experiment Video
Updated: Nov 28, 2025

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Effect of hyperglycemia on all-cause mortality from pediatric brain injury: A systematic review and meta-analysis
Shuyun Chen1,2, Zhaohe Liu1,2
1Department of Clinical Nutrition.
Insights
Hyperglycemia significantly increases all-cause mortality risk in pediatric brain injury patients. Further large-scale studies are needed to confirm this association.
Area of Science:
- Pediatric critical care medicine
- Neurology
- Endocrinology
Background:
- Hyperglycemia is a common metabolic disturbance in critically ill children.
- Brain injury in pediatric patients presents complex management challenges.
- The impact of hyperglycemia on outcomes in pediatric brain injury remains incompletely understood.
Purpose of the Study:
- To systematically review and meta-analyze the existing evidence on the association between hyperglycemia and all-cause mortality in pediatric patients with brain injury.
Main Methods:
- Systematic literature search of PubMed, Embase, and Cochrane Library databases.
- Inclusion of original observational studies assessing hyperglycemia and mortality in pediatric brain injury.
- Meta-analysis using a fixed-effects model; risk of bias and publication bias assessment.
Main Results:
- Nine observational studies with 970 pediatric patients (304 with hyperglycemia) were included.
- Hyperglycemia was strongly associated with increased all-cause mortality (OR = 11.60, 95% CI 7.88-17.08).
- No publication bias was detected, though study quality was generally low.
Conclusions:
- Hyperglycemia is significantly linked to higher all-cause mortality in pediatric brain injury.
- The findings highlight the critical importance of glycemic control in this vulnerable population.
- Further robust research, including large-scale observational studies and RCTs, is warranted to confirm these results.
Background:
This study aimed to assess the effect of hyperglycemia on all-cause mortality in pediatric patients with brain injury, based on currently available evidence.
Methods:
We systematically searched the PubMed, Embase, and Cochrane Library databases with the keywords "hyperglycemia", "brain injury", and "pediatrics". The retrieved records were screened by title, abstract, and full-text to include original articles assessing the effects of hyperglycemia on pediatric brain injury. The extracted data were assessed by a fixed-effects model. The risk of bias in the eligible studies was evaluated with the Newcastle-Ottawa Scale. Publication bias was visually examined with a funnel plot. Begg and Egger tests, respectively, were used to identify small-study effects. Sensitivity analysis was performed to evaluate the robustness of the original effect size.
Results:
Nine observational studies were identified from 1439 primary hits. A total of 970 pediatric patients, including 304 with hyperglycemia and brain injury, were included for meta-analysis. Hyperglycemia was strongly associated with a higher risk of all-cause mortality in pediatric patients (odds ratio = 11.60, 95% confidence interval [CI] 7.88-17.08; I = 0%). The overall quality of eligible studies was low, but the funnel plot indicated no publication bias.
Conclusions:
Hyperglycemia is significantly associated with high all-cause mortality in pediatric patients with brain injury. However, the relationship should be confirmed by larger-scale observational studies and randomized controlled trials.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

